Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

Jaap C Reijneveld; Martin JB Taphoorn; Corneel Coens; Jacoline EC Bromberg; Warren P Mason; Khe Hoang-Xuan; Gail Ryan; Mohamed Ben Hassel; Roelien H Enting; Alba A Brandes; Antje Wick; Olivier Chinot; Michele Reni; Guy Kantor; Brian Thiessen; Martin Klein; Eugenie Verger; Christian Borchers; Peter Hau; Michael Back; Anja Smits; Vassilis Golfinopoulos; Thierry Gorlia; Andrew Bottomley; Roger Stupp; Brigitta G Baumert

Journal article

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

Jaap C Reijneveld, Martin JB Taphoorn, Corneel Coens, Jacoline EC Bromberg, Warren P Mason, Khe Hoang-Xuan, Gail Ryan, Mohamed Ben Hassel, Roelien H Enting, Alba A Brandes, Antje Wick, Olivier Chinot, Michele Reni, Guy Kantor, Brian Thiessen, Martin Klein, Eugenie Verger, Christian Borchers, Peter Hau, Michael Back Show all

The Lancet Oncology | ELSEVIER SCIENCE INC | Published : 2016

DOI: 10.1016/S1470-2045(16)30305-9

University of Melbourne Researchers

Gail Ryan Author Clinical Pathology

Related Projects (1)

Radiotherapy vs. chemotherapy for low-grade gliomas, a rare brain tumour

Low-grade glioma is an uncommon malignant brain tumour. Surgery, radiotherapy and chemotherapy delay growth of this tumour, but cure is unco..

Grants

Awarded by Medical Research Council

Funding Acknowledgements

Merck Sharp & Dohme-Merck & Co, National Cancer Institute, Swiss Cancer League, National Institute for Health Research, Cancer Research UK, Canadian Cancer Society Research Institute, National Health and Medical Research Council, European Organisation for Research and Treatment of Cancer Cancer Research Fund.